Public Biotechnology Company Buys Cancer Vaccine Domain Names

In the most recent DNJournal weekly domain sales report, Ron Jackson reported the sale of two cancer vaccine domain names: sold for $18,000 and sold for $10,000. According to the updated Whois records for both domain names, the company that acquired them is a publicly traded pharmaceutical company called Northwest Biotherapeutics (Stock symbol: NWBO).

Additional research led me to find that the company also acquired as well. Up until August 1, the domain name was owned under privacy protection at Moniker, but the Whois lookup is now showing that it is owned by  Northwest Biotherapeutics at Go Daddy. Prior to its privacy protection in late 2012, it was owned by a domain investor in New Jersey.  It is possible the company had owned it at that point, and the privacy was removed after the transfer.

At the moment, it does not appear that the domain names are being utilized by the company.

I did a bit of cursory research on  Northwest Biotherapeutics, and on the company’s website, it mentions this: “The Company’s platform technology, DCVax ®, uses a patient’s own dendritic cells, the starter engine of the immune system. The dendritic cells are extracted from the body, loaded with tumor biomarkers or ”antigens”, thereby creating a personalized therapeutic vaccine.”

It’s a wise move for NWBO to own these particular domain names because it’s more likely that people will remember the words “cancer vaccine” rather than the company or product name. I am not familiar with pharmaceutical marketing, but I assume that they could use these generic domain names in marketing materials, making it easier for patients and medical professionals to remember how to navigate to the company website, assuming they plan to use these domain names in market.

Congratulations to  Northwest Biotherapeutics for getting these important domain names.

Previous article
Next article
Elliot Silver
Elliot Silver
About The Author: Elliot Silver is an Internet entrepreneur and publisher of Elliot is also the founder and President of Top Notch Domains, LLC, a company that has closed eight figures in deals. Please read the Terms of Use page for additional information about the publisher, website comment policy, disclosures, and conflicts of interest. Reach out to Elliot: Twitter | Facebook | LinkedIn


  1. There are a bunch of vaccine biotech companies out there. I remember trading in and out of this one years ago. If my memory serves correct they did a reverse split years ago. Hopefully, that whole sector will be able to get some breakthroughs in the near future for the disease. Nice story.

Leave a Reply

Recent Posts

Nick Huber: “drop a little coin” for a Premium Domain Name

I do not know Nick Huber, but I see he has a large following on Twitter and frequently offers advice to startup founders and...

Trademarkia Hiring Lead Developer for Domain Registrar Integration

Trademarkia is a website I use occasionally to perform trademark-related searches. This morning, I noticed a job listing the company posted on LinkedIn that...

SquadHelp Ultra Premium Marketplace Goes Live

🎉 It's here! The Ultra-Premium Marketplace is live We've partnered with @HilcoDigital to curate an incredible collection of domains. More additions coming soon! 🌟 Check it...

ROTD Auction Web3 Domain Names

According to a press release I received a moment ago, Right of the Dot is auctioning "Web3" domain names in partnership with Unstoppable Domains.... Dispute Gives Guidance on Common One Word Domains

The latest #UDRP Digest (Vol 3.37) is out now! Read about some interesting cases including,, and more, with commentary from @dnattorney...